Taysha Gene Therapies, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Taysha Gene Therapies, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q3 2024.
  • Taysha Gene Therapies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 13, 2024 was 205M shares, a 9.62% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 205M +18M +9.62% Nov 13, 2024 10-Q 2024-11-13
Q2 2024 205M +140M +218% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 187M +124M +195% Mar 19, 2024 10-K 2024-03-19
Q3 2023 187M +125M +199% Nov 14, 2023 10-Q 2023-11-14
Q2 2023 64.5M +23.4M +56.9% Aug 14, 2023 10-Q 2023-08-14
Q1 2023 63.5M +25M +65% Mar 28, 2023 10-K 2023-03-28
Q3 2022 62.4M +24M +62.3% Nov 8, 2022 10-Q 2022-11-08
Q2 2022 41.1M Aug 11, 2022 10-Q 2022-08-11
Q1 2022 38.5M +713K +1.89% Mar 31, 2022 10-K 2022-03-31
Q3 2021 38.5M +713K +1.89% Nov 10, 2021 10-Q 2021-11-10
Q1 2021 37.8M Mar 3, 2021 10-K 2021-03-03
Q3 2020 37.8M Nov 12, 2020 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.